JOSEPH PHAM: Open Payments
NPI 1982996088 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 54 payments from 12 companies in 2025. Trend: 2023 $1,003 · 2024 $1,093 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $274 |
| Inspire Medical Systems, Inc. | 1 | $180 |
| Lilly USA, LLC | 10 | $167 |
| PFIZER INC. | 9 | $158 |
| Abbott Laboratories | 6 | $135 |
| ABBVIE INC. | 3 | $50 |
| Amgen Inc. | 3 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: INSPIRE, MOUNJARO, Wegovy, FREESTYLE LIBRE 3, NURTEC ODT, ELIQUIS, SPRAVATO, Rybelsus.
Industry payments across TX — which companies pay providers there.
